Editor's Blog
Features
Social listening in healthcare: is it irresponsible?
There’s a quietly emerging niche in the healthcare industry: social listening for marketable data. But is it moral? And is it safe? Read more
GSK in China: time to crack down on Big Pharma?
Online editor Dave Gray looks back on the conclusion of GSK's turbulence in China, and asks what impact this will have on pharma trading around the world. Read more
Back to the dark ages?
Lu Rahman, EPM group editor, discusses issues surrounding antibiotic resistance Read more
Pfizer’s possible takeover of AstraZeneca — a not so wise move for the UK?
The UK’s largest drug maker AstraZeneca yesterday rejected a second takeover bid of £60 billion from US rival Pfizer, the first being £58.8 billion and made in January. AstraZeneca said it had rejected the offers on account of their “very... Read more
TSAR Predict service solves age-old 'sticking' conundrum in hours
It is a year since I first spoke to I Holland Ltd’s research, development & quality systems manager Rob Blanchard about I Holland and the University of Nottingham’s School of Pharmacy’s TSAR (Tabletting Science and Anti-Stick Research) project... Read more